83 FR 53108 - Importer of Controlled Substances Application: Fisher Clinical Services, Inc.

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 83, Issue 203 (October 19, 2018)

Page Range		53108-53108
FR Document		2018-22828

Federal Register, Volume 83 Issue 203 (Friday, October 19, 2018)

[Federal Register Volume 83, Number 203 (Friday, October 19, 2018)]
[Notices]
[Page 53108]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-22828]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Fisher Clinical 
Services, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before November 19, 2018. 
Such persons may also file a written request for a hearing on the 
application on or before November 19, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on June 
4, 2018, Fisher Clinical Services, Inc., 7554 Schantz Road, Allentown, 
Pennsylvania 18106 applied to be registered as an importer of the 
following basic class of controlled substance:

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Psilocybin.........................            7437  I
------------------------------------------------------------------------

    The company plans to import the listed controlled substance for 
clinical trials.

    Dated: October 10, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-22828 Filed 10-18-18; 8:45 am]
 BILLING CODE 4410-09-P

53108 Federal Register / Vol. 83, No. 203 / Friday, October 19, 2018 / Notices

Controlled substance Drug code Schedule

Marihuana ........................................................................................................................................................................ 7360 I
Tetrahydrocannabinols .................................................................................................................................................... 7370 I
Nabilone ........................................................................................................................................................................... 7379 II
Phenylacetone ................................................................................................................................................................. 8501 II
Thebaine .......................................................................................................................................................................... 9333 II
Poppy Straw Concentrate ............................................................................................................................................... 9670 II
Tapentadol ....................................................................................................................................................................... 9780 II

The company plans to import DEPARTMENT OF JUSTICE Representative/DPW, 8701 Morrissette
phenylacetone (8501), and poppy straw Drive, Springfield, Virginia 22152.
concentrate (9670) to bulk manufacture Drug Enforcement Administration
other controlled substances for SUPPLEMENTARY INFORMATION: The
[Docket No. DEA–392] Attorney General has delegated his
distribution to its customers. The
company plans to import an authority under the Controlled
Importer of Controlled Substances Substances Act to the Administrator of
intermediate form of tapentadol (9780) Application: Fisher Clinical Services,
to bulk manufacture tapentadol (9780) the Drug Enforcement Administration
Inc.
for distribution to its customers. (DEA), 28 CFR 0.100(b). Authority to
The company plans to import ACTION: Notice of application. exercise all necessary functions with
impunities of buprenorphine that have respect to the promulgation and
been determined by DEA to be captured DATES: Registered bulk manufacturers of implementation of 21 CFR part 1301,
under drug code (9333) thebaine. the affected basic classes, and incident to the registration of
In reference to drug codes 7360 and applicants therefore, may file written manufacturers, distributors, dispensers,
7370, the company plans to import a comments on or objections to the importers, and exporters of controlled
synthetic cannabidiol and a synthetic issuance of the proposed registration on substances (other than final orders in
tetrahydrocannabinol. No other activity or before November 19, 2018. Such connection with suspension, denial, or
for these drug codes is authorized for persons may also file a written request revocation of registration) has been
this registration. Placement of these for a hearing on the application on or redelegated to the Assistant
drug codes onto the company’s before November 19, 2018. Administrator of the DEA Diversion
registration does not translate into
ADDRESSES: Written comments should Control Division (‘‘Assistant
automatic approval of subsequent
permit applications to import controlled be sent to: Drug Enforcement Administrator’’) pursuant to section 7 of
substances. Approval of permit Administration, Attention: DEA Federal 28 CFR part 0, appendix to subpart R.
applications will occur only when the Register Representative/DPW, 8701 In accordance with 21 CFR
registrant’s business activity is Morrissette Drive, Springfield, Virginia
1301.34(a), this is notice that on June 4,
consistent with what is authorized 22152. All requests for hearing must be
2018, Fisher Clinical Services, Inc.,
under 21 U.S.C. 952(a)(2). Authorization sent to: Drug Enforcement
7554 Schantz Road, Allentown,
will not extend to the import of FDA Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield, Pennsylvania 18106 applied to be
approved or non-approved finished registered as an importer of the
dosage forms for commercial sale. Virginia 22152. All requests for hearing
should also be sent to: (1) Drug following basic class of controlled
Dated: October 10, 2018. Enforcement Administration, Attn: substance:
John J. Martin, Hearing Clerk/OALJ, 8701 Morrissette
Assistant Administrator. Drive, Springfield, Virginia 22152; and
[FR Doc. 2018–22832 Filed 10–18–18; 8:45 am] (2) Drug Enforcement Administration,
BILLING CODE 4410–09–P Attn: DEA Federal Register

Controlled substance Drug code Schedule

Psilocybin ......................................................................................................................................................................... 7437 I

The company plans to import the DEPARTMENT OF JUSTICE SUMMARY: The Department of Justice
listed controlled substance for clinical (DOJ), Office of Justice Programs,
[OMB Number 1121–0184]
trials. Bureau of Justice Statistics, will be
Agency Information Collection submitting the following information
Dated: October 10, 2018.
Activities; Proposed eCollection collection request to the Office of
John J. Martin, Management and Budget (OMB) for
eComments Requested; Revision of a
Assistant Administrator. review and approval in accordance with
Currently Approved Collection;
[FR Doc. 2018–22828 Filed 10–18–18; 8:45 am]
Comments Requested: 2019 School the Paperwork Reduction Act of 1995.
amozie on DSK3GDR082PROD with NOTICES1

BILLING CODE 4410–09–P Crime Supplement (SCS) to the DATES: Comments are encouraged and
National Crime Victimization Survey will be accepted for 30 days until
(NCVS) November 19, 2018.
AGENCY: Bureau of Justice Statistics, FOR FURTHER INFORMATION CONTACT: If
Department of Justice. you have additional comments
especially on the estimated public
ACTION: 30-Day notice.
burden or associated response time,

VerDate Sep<11>2014 17:25 Oct 18, 2018 Jkt 247001 PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 E:\FR\FM\19OCN1.SGM 19OCN1

Document Created: 2018-10-19 01:25:38
Document Modified: 2018-10-19 01:25:38

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of application.
Dates		Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before November 19, 2018. Such persons may also file a written request for a hearing on the application on or before November 19, 2018.
FR Citation		83 FR 53108

83 FR 53108 - Importer of Controlled Substances Application: Fisher Clinical Services, Inc.

DEPARTMENT OF JUSTICEDrug Enforcement Administration

Federal Register Volume 83, Issue 203 (October 19, 2018)

DEPARTMENT OF JUSTICE
Drug Enforcement Administration